AMLX

NASDAQStock

Amylyx Pharmaceuticals, Inc.

$14.39-0.54 (-3.58%)

52-Week Range

$3.31

$16.92

Key Stats

Market Cap

1.2B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

-0.30

Volume

627.3K

Avg Volume

1.1M

Performance

+0.21%

+14.49%

+21.35%

YTD

+25.92%

+291.83%

-57.83%

-20.42%

Price Chart

ETF Exposure

AMLX is held by 63 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
EAOK	iShares ESG Aware 30/70 Conservative Allocation ETF	0.00%	6	$95	$9.0M	0.30%
EAOM	iShares ESG Aware 40/60 Moderate Allocation ETF	0.00%	8	$117	$8.3M	0.31%
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	43	$637	$30.3M	0.32%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	48	$724	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	57	$858	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	48	$714	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	31	$471	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	24	$356	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	11	$158	$9.5M	0.12%
DXUV	Dimensional - US Vector Equity ETF	0.00%	8	$119	$358.0M	0.28%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	7	$111	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	25	$370	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	42	$629	$81.7M	0.11%

PreviousPage 2 of 2

About AMLX ETF Exposure

Amylyx Pharmaceuticals, Inc. (AMLX) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.2B, AMLX is a widely held institutional stock. The stock currently trades at $14.39. Investors can gain exposure to AMLX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AMLX, sorted by portfolio weight.